174 related articles for article (PubMed ID: 27016067)
1. The Ameliorated Pharmacokinetics of VP-16 in Wistar Rats: A Possible Role of P-Glycoprotein Inhibition by Pharmaceutical Excipients.
Akhtar N; Ahad A; Khan MF; Allaham A; Talegaonkar S
Eur J Drug Metab Pharmacokinet; 2017 Apr; 42(2):191-199. PubMed ID: 27016067
[TBL] [Abstract][Full Text] [Related]
2. Enhanced oral paclitaxel absorption with vitamin E-TPGS: effect on solubility and permeability in vitro, in situ and in vivo.
Varma MV; Panchagnula R
Eur J Pharm Sci; 2005; 25(4-5):445-53. PubMed ID: 15890503
[TBL] [Abstract][Full Text] [Related]
3. Enhanced intestinal absorption of etoposide by self-microemulsifying drug delivery systems: roles of P-glycoprotein and cytochrome P450 3A inhibition.
Zhao G; Huang J; Xue K; Si L; Li G
Eur J Pharm Sci; 2013 Nov; 50(3-4):429-39. PubMed ID: 23981337
[TBL] [Abstract][Full Text] [Related]
4. Effects of lipid vehicle and P-glycoprotein inhibition on the mesenteric lymphatic transport of paclitaxel in unconscious, lymph duct-cannulated rats.
Cai Q; Deng X; Li Z; An D; Shen T; Zhong M
Drug Deliv; 2016; 23(1):147-53. PubMed ID: 24786483
[TBL] [Abstract][Full Text] [Related]
5. Lipid excipients Peceol and Gelucire 44/14 decrease P-glycoprotein mediated efflux of rhodamine 123 partially due to modifying P-glycoprotein protein expression within Caco-2 cells.
Sachs-Barrable K; Thamboo A; Lee SD; Wasan KM
J Pharm Pharm Sci; 2007; 10(3):319-31. PubMed ID: 17727795
[TBL] [Abstract][Full Text] [Related]
6. Enhancing effect of N-octyl-O-sulfate chitosan on etoposide absorption.
Mo R; Xiao Y; Sun M; Zhang C; Ping Q
Int J Pharm; 2011 May; 409(1-2):38-45. PubMed ID: 21356302
[TBL] [Abstract][Full Text] [Related]
7. Novel flavonoid-based biodegradable nanoparticles for effective oral delivery of etoposide by P-glycoprotein modulation: an in vitro, ex vivo and in vivo investigations.
Fatma S; Talegaonkar S; Iqbal Z; Panda AK; Negi LM; Goswami DG; Tariq M
Drug Deliv; 2016; 23(2):500-11. PubMed ID: 24937381
[TBL] [Abstract][Full Text] [Related]
8. Co-treatment with grapefruit juice inhibits while chronic administration activates intestinal P-glycoprotein-mediated drug efflux.
Panchagnula R; Bansal T; Varma MV; Kaul CL
Pharmazie; 2005 Dec; 60(12):922-7. PubMed ID: 16398269
[TBL] [Abstract][Full Text] [Related]
9. Microdialysis assessment of microfibrous collagen containing a P-glycoprotein-mediated transport inhibitor, cyclosporine A, for local delivery of etoposide.
Sato H; Kitazawa H; Adachi I; Horikoshi I
Pharm Res; 1996 Oct; 13(10):1565-9. PubMed ID: 8899852
[TBL] [Abstract][Full Text] [Related]
10. Oral microemulsions of paclitaxel: in situ and pharmacokinetic studies.
Nornoo AO; Zheng H; Lopes LB; Johnson-Restrepo B; Kannan K; Reed R
Eur J Pharm Biopharm; 2009 Feb; 71(2):310-7. PubMed ID: 18793723
[TBL] [Abstract][Full Text] [Related]
11. Polysorbate 20 alters the oral bioavailability of etoposide in wild type and mdr1a deficient Sprague-Dawley rats.
Al-Ali AAA; Quach JRC; Bundgaard C; Steffansen B; Holm R; Nielsen CU
Int J Pharm; 2018 May; 543(1-2):352-360. PubMed ID: 29635055
[TBL] [Abstract][Full Text] [Related]
12. Involvement of P-glycoprotein and CYP 3A4 in the enhancement of etoposide bioavailability by a piperine analogue.
Najar IA; Sharma SC; Singh GD; Koul S; Gupta PN; Javed S; Johri RK
Chem Biol Interact; 2011 Apr; 190(2-3):84-90. PubMed ID: 21333639
[TBL] [Abstract][Full Text] [Related]
13. Effects of quercetin on the pharmacokinetics of Etoposide after oral or intravenous administration of etoposide in rats.
Li X; Choi JS
Anticancer Res; 2009 Apr; 29(4):1411-5. PubMed ID: 19414395
[TBL] [Abstract][Full Text] [Related]
14. Excipients enhance intestinal absorption of ganciclovir by P-gp inhibition: assessed in vitro by everted gut sac and in situ by improved intestinal perfusion.
Li M; Si L; Pan H; Rabba AK; Yan F; Qiu J; Li G
Int J Pharm; 2011 Jan; 403(1-2):37-45. PubMed ID: 20969937
[TBL] [Abstract][Full Text] [Related]
15. Effects of Pluronic F68 and Labrasol on the intestinal absorption and pharmacokinetics of rifampicin in rats.
Ma L; Wei Y; Zhou Y; Ma X; Wu X
Arch Pharm Res; 2011 Nov; 34(11):1939-43. PubMed ID: 22139693
[TBL] [Abstract][Full Text] [Related]
16. Enhanced bioavailability of etoposide after oral or intravenous administration of etoposide with kaempferol in rats.
Li C; Li X; Choi JS
Arch Pharm Res; 2009 Jan; 32(1):133-8. PubMed ID: 19183886
[TBL] [Abstract][Full Text] [Related]
17. Development of an oral solid dispersion formulation for use in low-dose metronomic chemotherapy of paclitaxel.
Moes J; Koolen S; Huitema A; Schellens J; Beijnen J; Nuijen B
Eur J Pharm Biopharm; 2013 Jan; 83(1):87-94. PubMed ID: 23085332
[TBL] [Abstract][Full Text] [Related]
18. Enhanced oral bioavailability of morin administered in mixed micelle formulation with PluronicF127 and Tween80 in rats.
Choi YA; Yoon YH; Choi K; Kwon M; Goo SH; Cha JS; Choi MK; Lee HS; Song IS
Biol Pharm Bull; 2015; 38(2):208-17. PubMed ID: 25747979
[TBL] [Abstract][Full Text] [Related]
19. Development of novel self-assembled DS-PLGA hybrid nanoparticles for improving oral bioavailability of vincristine sulfate by P-gp inhibition.
Ling G; Zhang P; Zhang W; Sun J; Meng X; Qin Y; Deng Y; He Z
J Control Release; 2010 Dec; 148(2):241-8. PubMed ID: 20727928
[TBL] [Abstract][Full Text] [Related]
20. Relationships between the hydrophilic-lipophilic balance values of pharmaceutical excipients and their multidrug resistance modulating effect in Caco-2 cells and rat intestines.
Lo YL
J Control Release; 2003 Jun; 90(1):37-48. PubMed ID: 12767705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
